Cutaneous mast cell depletion results from topical corticosteroid usage

Area of Science:

• Dermatology
• Immunology
• Cell Biology

Background:

• Topical corticosteroids are widely used for inflammatory skin conditions.
• The impact of long-term corticosteroid use on cutaneous mast cells is not fully understood.

Purpose of the Study:

• To investigate the long-term effects of topical corticosteroids on human cutaneous mast cells.
• To determine the reversibility of corticosteroid-induced mast cell depletion.

Main Methods:

• Human skin biopsies were analyzed using electron microscopy after 6 weeks of potent topical corticosteroid treatment.
• Histamine levels were measured before, during, and after treatment.
• Mast cell morphology and density were assessed at various time points.

Main Results:

• Potent corticosteroids (clobetasol-17-propionate, fluocinonide) significantly decreased histamine content (>85%) and mast cells.
• Less potent betamethasone valerate caused a 66% decrease in histamine.
• Mast cell depletion was evident after 3 weeks, with signs of degeneration; recovery of mast cells and histamine levels took up to 3 months post-treatment.

Conclusions:

• Long-term topical corticosteroid application is toxic to cutaneous mast cells, leading to their depletion.
• While skin structure recovers rapidly after treatment cessation, mast cell regeneration is a slow process.
• These findings highlight the reversible, yet potentially prolonged, impact of corticosteroids on skin mast cells.